Thoracic duct fistula and renal transplantation.

PubWeight™: 1.60‹?› | Rank: Top 4%

🔗 View Article (PMC 1344512)

Published in Ann Surg on October 01, 1979

Authors

T E Starzl, R Weil, L J Koep, R T McCalmon, P I Terasaki, Y Iwaki, G P Schröter, J J Franks, V Subryan, C G Halgrimson

Articles citing this

Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Decline in survival after liver transplantation. Arch Surg (1980) 1.39

The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13

Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest (1997) 1.04

Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet (1981) 1.01

A search for an enriched source of polymeric IgA in human thoracic duct lymph, portal vein blood and aortic blood. Clin Exp Immunol (1982) 0.84

Renal transplantation after thoracic duct drainage. Ann Surg (1981) 0.80

Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. Transplant Proc (1980) 0.79

Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation. Transplant Proc (1981) 0.79

Science, specialization, and the American Surgical Association. Ann Surg (1997) 0.78

Exploring the feasibility of selective depletion of T lymphocyte subsets by whole blood immunoadsorption cytapheresis. Clin Exp Immunol (2007) 0.75

Could a simple surgical intervention eliminate HIV infection? Theor Biol Med Model (2004) 0.75

Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. Transplantation (1996) 0.75

DR-bearing T lymphocytes in thoracic duct lymph. Clin Immunol Immunopathol (1981) 0.75

Effect of preoperative thoracic duct drainage on canine kidney transplantation. J Invest Surg (1997) 0.75

Articles cited by this

Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35

Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22

THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

The recirculation of lymphocytes from blood to lymph in the rat. J Physiol (1959) 7.09

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med (1963) 5.14

RENAL HOMOTRANSPLANTATION IN MAN IN MODIFIED RECIPIENTS. Ann Surg (1963) 4.13

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34

Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06

THE ANTIBODY RESPONSE OF RATS DEPLETED OF LYMPHOCYTES BY CHRONIC DRAINAGE FROM THE THORACIC DUCT. J Exp Med (1963) 2.80

HOMOTRANSPLANTATION OF KIDNEY IN PATIENTS TREATED BY PREOPERATIVE LOCAL IRRADIATION AND POSTOPERATIVE ADMINISTRATION OF AN ANTIMETABOLITE (IMURAN). REPORT OF SIX CASES. Lancet (1963) 2.04

Specific properties of human B and T lymphocytes and alterations in disease. Transplant Rev (1973) 1.79

SURVIVAL OF HOMOGRAFTS OF SKIN IN RATS DEPLETED OF LYMPHOCYTES BY CHRONIC DRAINAGE FROM THE THORACIC DUCT. Lancet (1964) 1.70

Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70

Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63

HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56

Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery (1978) 1.50

Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26

Immunologic preparation for cadaver renal transplant by thoracic duct drainage. Transplant Proc (1977) 1.24

Thoracic duct drainage in organ transplantation: will it permit better immunosuppression? Transplant Proc (1979) 1.21

Drainage of thoracic duct lymph in renal transplant patients. Transplantation (1976) 1.21

Identification of unresponsive kidney-transplant recipients. Lancet (1972) 1.16

100 second renal allografts from a single transplantation institution. Transplantation (1979) 1.14

The immunosuppressive effect of thoracic duct drainage in human kidney transplantation. Ann Intern Med (1970) 1.12

THE SUPPRESSION OF IMMUNOLOGIC ACTIVITY BY DIVERSION OF THORACIC DUCT LYMPH. Ann Surg (1964) 1.11

Prognosis after renal transplantation: cumulative influence of combined risk factors. Transplantation (1979) 1.08

Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation (1978) 1.06

Proceedings: The outcome of kidney retransplantation. Arch Surg (1974) 1.06

Immunologic competence in the lymph-dialyzed patient. Surg Gynecol Obstet (1969) 1.06

Depletion of lymphocytes for the protection of renal allografts. Arch Intern Med (1970) 1.05

Use of thoracic duct drainage in human renal transplantation. Surg Forum (1977) 1.02

The immunologic consequences of lymph lymphocyte depletion. Surg Forum (1969) 1.01

Kidney transplantation. Modern trends in kidney transplantation. Transplant Proc (1977) 0.97

[Technic, surveillance and value of the drainage of the thoracic duct, executed in view of a renal transplantation]. J Chir (Paris) (1969) 0.96

Preformed cytotoxic antibody in patients subjected to thoracic duct drainage. Proc Clin Dial Transplant Forum (1975) 0.95

Prolonged thoracic duct lymph drainage. Application for human renal homotransplantation. Arch Surg (1966) 0.91

THE BIOLOGIC BASIS OF TISSUE TRANSPLANTATION. Surg Clin North Am (1965) 0.91

EFFECT OF THORACIC DUCT LYMPH DRAINAGE ON THE IMMUNE RESPONSE IN MAN. Surg Gynecol Obstet (1965) 0.91

Effect of antilyphocyte-globulin potency on survival of cadaver renal transplants. Prospective randomised double-blind trial. Lancet (1977) 0.91

Thoracic duct drainage in human kidney allotransplantation. Rev Bras Pesqui Med Biol (1975) 0.89

Retrospective tests of B-cold lymphocytotoxins and transplant survival at a single center. Transplant Proc (1979) 0.85

Renal transplantation in the presence of a positive crossmatch. Transplant Proc (1978) 0.83

Kidney transplantation across positive B and T cell crossmatches. Transplantation (1978) 0.78

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

Kidney transplantation under FK 506. JAMA (1990) 7.45

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther (1998) 3.77

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Induction of cellular DNA synthesis by polyoma virus. Proc Natl Acad Sci U S A (1965) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

Changes in blood coagulation. Arch Surg (1966) 3.22